Valsartan benefits left ventricular structure and function in heart failure: Val-HeFT echocardiographic study

The objective of the study was to evaluate the effect of an angiotensin receptor blocker on left ventricular (LV) structure and function when added to prescribed heart failure therapy. The clinical benefit derived from heart failure therapy is attributed to the regression of LV remodeling. At 302 mu...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the American College of Cardiology 2002-09, Vol.40 (5), p.970-975
Hauptverfasser:	Wong, Maylene, Staszewsky, Lidia, Latini, Roberto, Barlera, Simona, Volpi, Alberto, Chiang, Yann-Tong, Benza, Raymond L, Gottlieb, Sidney O, Kleemann, Thomas D, Rosconi, Franco, Vandervoort, Pieter M, Cohn, Jay N
Format:	Artikel
Sprache:	eng
Schlagworte:	Accuracy Adrenergic beta-Antagonists - therapeutic use Age Aged Angiotensin Receptor Antagonists Angiotensin-Converting Enzyme Inhibitors - therapeutic use Antihypertensive Agents - pharmacology Antihypertensive Agents - therapeutic use Biological and medical sciences Cardiology Cardiovascular system Drug therapy Echocardiography Enzymes Female Gender Heart attacks Heart failure Heart Failure - drug therapy Heart Failure - physiopathology Humans Male Medical sciences Middle Aged Miscellaneous Morbidity Mortality Pharmacology. Drug treatments Population Quality of life Reading Tetrazoles - pharmacology Tetrazoles - therapeutic use Valine - analogs & derivatives Valine - pharmacology Valine - therapeutic use Valsartan Ventricular Function, Left - drug effects Ventricular Remodeling - drug effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!